# Revolution Medicines stock price target kept at $270 by TD Cowen on cancer data

- Source: All News
- Published: 2026-11-20T15:06:46+00:00
- Category: Business
- Original: https://www.investing.com/news/analyst-ratings/revolution-medicines-stock-price-target-kept-at-270-by-td-cowen-on-cancer-data-93CH-5042127
- Canonical: https://groundlevelnews.com/story/revolution-medicines-stock-price-target-kept-at-270-by-td-cowen-on-can-25ea29/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to All News._
